ExploreWatchlistsPricing
  1. JP-listed companies
  2. CHUGAI PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Pretax margin (%)

CHUGAI PHARMACEUTICAL CO., LTD. (4519)

Market cap
¥12.38T
P/E ratio
26.8x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Dec 31, 202547.5+2.44%
Dec 31, 202446.4+16.16%
Dec 31, 202339.9-5.27%
Dec 31, 202242.2+0.50%
Dec 31, 202141.9+10.71%
Dec 31, 202037.9+25.07%
Dec 31, 201930.3+44.64%
Dec 31, 201820.9+15.32%
Dec 31, 201718.2+19.98%
Dec 31, 201615.1-13.47%
Dec 31, 201517.5+5.92%
Dec 31, 201416.5-9.51%
Dec 31, 201318.3-5.29%
Dec 31, 201219.3+13.22%
Dec 31, 201117

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat